Suppr超能文献

马使用低剂量钙肝素:血浆肝素浓度、对红细胞量及凝血变量的影响

Low dose calcium heparin in horses: plasma heparin concentrations, effects on red blood cell mass and on coagulation variables.

作者信息

Gerhards H

机构信息

Clinic for Horses, Hannover School of Veterinary Medicine, Germany.

出版信息

Equine Vet J. 1991 Jan;23(1):37-43. doi: 10.1111/j.2042-3306.1991.tb02711.x.

Abstract

Low dose calcium heparin was administered subcutaneously at 12 hourly intervals to six healthy horses at an initial dose of 150 iu of heparin/kg bodyweight (bwt) and at a maintenance dose of 120 iu/kg bwt. All injections were given at 0900 and 2100 h. Blood samples for monitoring plasma heparin concentrations were obtained prior to, at 2 hourly intervals for 84 h (treatment period), and at Hours 24, 32, 48 and 96 of the control period. Blood samples for monitoring red blood cell (RBC) mass, plasma antithrombin III activity (AT III), activated partial thromboplastin time (APTT), and thrombin time (TT) were taken at 8 hourly intervals during the treatment period and at all of the Control Period Hours. Mean plasma heparin concentrations increased significantly (P less than 0.01) from 2 h after the first to 32 h after the last (seventh) injection. Mean values corresponding to the desired range of heparin in plasma (0.05 to 0.20 iu/ml) were achieved at 21 h after initiation of heparin treatment and were maintained during the following 81 h. Great individual variations in the sensitivity to heparin among horses, cumulation of heparin in plasma with prolonged administration and a marked circadian periodicity in the disposition of heparin affected actually measured plasma heparin values. A chronodiagram revealed peak values around 1300 h, trough values around 0500 h. The peak-trough difference amounted to about 50 per cent. Increasing plasma heparin concentrations were associated with erratic prolongations of mean APTT and TT values. The AT III curve was not affected significantly.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对6匹健康马匹每12小时皮下注射低剂量钙肝素,初始剂量为150国际单位肝素/千克体重,维持剂量为120国际单位/千克体重。所有注射均在09:00和21:00进行。在给药前、治疗期84小时内每2小时一次以及对照期的24、32、48和96小时采集血样监测血浆肝素浓度。在治疗期每8小时一次以及对照期所有时间点采集血样监测红细胞(RBC)数量、血浆抗凝血酶III活性(AT III)、活化部分凝血活酶时间(APTT)和凝血酶时间(TT)。从首次注射后2小时到最后一次(第七次)注射后32小时,平均血浆肝素浓度显著升高(P<0.01)。肝素治疗开始后21小时达到血浆中肝素期望范围(0.05至0.20国际单位/毫升)的平均值,并在随后81小时内维持。马匹对肝素的敏感性个体差异很大,随着给药时间延长血浆中肝素会蓄积,并且肝素处置存在明显的昼夜周期性,这些都影响了实际测得的血浆肝素值。时间图表显示峰值出现在13:00左右,谷值出现在05:00左右。峰谷差值约为50%。血浆肝素浓度升高与平均APTT和TT值的不规则延长相关。AT III曲线未受到显著影响。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验